Association of clinical severity with FANCB variant type in Fanconi anemia.
Clicks: 225
ID: 98370
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
225 views
34 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #15 of 28 articles by views in Blood
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Fanconi anemia (FA) is the most common genetic cause of bone marrow failure, and is caused by inherited pathogenic variants in any of 22 genes. Of these, only FANCB is X-linked. We describe a cohort of 19 children with FANCB variants, from 16 families of the International Fanconi Anemia Registry (IFAR). Those with FANCB deletion or truncation demonstrate earlier than average onset of bone marrow failure, and more severe congenital abnormalities compared to a large series of FA individuals in the published reports. This reflects the indispensable role of FANCB protein in the enzymatic activation of FANCD2 monoubiquitination, an essential step in the repair of DNA interstrand crosslinks. For FANCB missense variants, more variable severity is associated with the extent of residual FANCD2 monoubiquitination activity. We used transcript analysis, genetic complementation, and biochemical reconstitution of FANCD2 monoubiquitination to determine the pathogenicity of each variant. Aberrant splicing and transcript destabilization were associated with two missense variants. Individuals carrying missense variants with drastically reduced FANCD2 monoubiquitination in biochemical and/or cell-based assays tended to show earlier onset of hematologic disease and shorter survival. Conversely, variants with near-normal FANCD2 monoubiquitination were associated with more favorable outcome. Our study reveals a genotype-phenotype correlation within the FA-B complementation group of FA, where severity associates with the level of residual FANCD2 monoubiquitination.
| Reference Key |
jung2020associationblood
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Jung, Moonjung;Ramanagoudr-Bhojappa, Ramanagouda;van Twest, Sylvie;Rosti, Rasim Ozgur;Murphy, Vincent;Tan, Winnie;Donovan, Frank X;Lach, Francis P;Kimble, Danielle C;Jiang, Caroline;Vaughan, Roger;Mehta, Parinda A;Pierri, Filomena;Doufour, Carlo;Auerbach, Arleen D;Deans, Andrew;Smogorzewska, Agata;Chandrasekharappa, Settara C; |
| Journal | Blood |
| Year | 2020 |
| DOI |
blood.2019003249
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.